Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs

To evaluate the onset timing of musculoskeletal adverse events (MAEs) that develop during statin monotherapy and to determine whether concomitant drugs used concurrently with statin therapy shifts the onset timing of MAEs. Cases in which statins (atorvastatin, rosuvastatin, simvastatin, lovastatin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimoto, Hayato, Negishi, Akio, Oshima, Shinji, Okita, Mitsuyoshi, Numajiri, Sachihiko, Inoue, Naoko, Ohshima, Shigeru, Kobayashi, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220123/
https://www.ncbi.nlm.nih.gov/pubmed/30443347
http://dx.doi.org/10.1002/prp2.439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220123/
https://www.ncbi.nlm.nih.gov/pubmed/30443347
http://dx.doi.org/10.1002/prp2.439

Ejemplares similares